Menu Search
Equities

BioMaxima SA

944:FRA

BioMaxima SA

Actions
  • Price (EUR)2.76
  • Today's Change-0.06 / -2.13%
  • Shares traded--
  • 1 Year change-17.24%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 14:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year BioMaxima SA's revenues fell -67.22% from 145.51m to 47.69m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 28.89m to 586.00k, a -97.97% decrease.
Gross margin46.17%
Net profit margin-0.91%
Operating margin-0.61%
Return on assets-0.62%
Return on equity-0.93%
Return on investment-0.74%
More ▼

Cash flow in PLNView more

In 2023, cash reserves at BioMaxima SA fell by 11.40m. Cash Flow from Financing totalled 4.25m or 8.92% of revenues. In addition the company generated 1.59m in cash from operations while cash used for investing totalled 17.25m.
Cash flow per share0.6203
Price/Cash flow per share23.39
Book value per share11.11
Tangible book value per share11.03
More ▼

Balance sheet in PLNView more

BioMaxima SA has a Debt to Total Capital ratio of 20.82%, a higher figure than the previous year's 7.35%.
Current ratio1.83
Quick ratio0.7783
Total debt/total equity0.2629
Total debt/total capital0.2082
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.